Medical oncologist Dr. R. Julie Brahmer discusses biomarker testing and advanced treatment for lung cancer patients.
Physicians and researchers at the Netherlands Cancer Institute have developed an AI model that outperforms physicians in evaluating treatment response in pleural mesothelioma. Far more accurate than ...
A new study suggests that a blood-based protein signature may help identify people at risk of lung cancer more accurately ...
Ivonescimab's landmark overall survival win against PD-1 in their chemotherapy combinations in first-line lung cancer drew both hope and criticism at ASCO 2026. (Angus Liu/Fierce Pharma) It’s the ...
Cambridge scientists hunting tell-tale killer ‘zombie’ cells that signal early lung cancer have developed a world-first urine test that could transform diagnosis and survival for thousands of patients ...
This Nature Outlook is editorially independent, produced with financial support from Daiichi Sankyo and MSD. About this content. A cancer diagnosis of any kind portends a rough road ahead, but that ...
Professor Jinyang Liang, specializing in ultrafast imaging and biophotonics at INRS, has developed with colleagues at INRS and Université de Montréal a minimally invasive technology to detect skin ...
Abstract: Lung cancer is a serious disease which forms cancer cells that lines the air passages of the lungs. It has become a leading cause of death in both men and women due to lifestyles. Early ...
WASHINGTON—The Department of Health and Human Services has found a new lever to cut off billions in federal funding that it believes is wasteful or potentially fraudulent, a move that could affect ...
First-line amivantamab plus lazertinib achieved 41.0-month median OS in atypical EGFR-mutant NSCLC, with 55% alive at 3 years and safety consistent with prior reporting. Dual PD-L1/VEGF-A bispecific ...
Abstract: Cervical cancer is one of the most common causes of mortality among women globally. Development of accurate, interpretable and clinically deployable automated systems for detection of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results